发明授权
US07357931B2 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
有权
血清淀粉样蛋白a基因在青光眼诊断和治疗中的应用及抗青光眼药物鉴定
- 专利标题： Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
- 专利标题（中）： 血清淀粉样蛋白a基因在青光眼诊断和治疗中的应用及抗青光眼药物鉴定
-
申请号： US11000757申请日： 2004-12-01
-
公开(公告)号： US07357931B2公开(公告)日： 2008-04-15
- 发明人: Abbot F. Clark , Wan-Heng Wang , Loretta McNatt
- 申请人： Abbot F. Clark , Wan-Heng Wang , Loretta McNatt
- 申请人地址： CH Hunenberg
- 专利权人： Alcon, Inc.
- 当前专利权人： Alcon, Inc.
- 当前专利权人地址： CH Hunenberg
- 代理商 Teresa J. Schultz
- 主分类号： A61K39/00
- IPC分类号： A61K39/00
摘要：
The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A.